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Abstract
My research initially began with the goal of identifying substrates of the C. 
elegans protein tyrosine phosphatase ptp-3 through the use of quantitative mass 
spectrometry. To identify substrates of ptp-3, we employed stable isotope labeling by 
amino acids in cell culture (SILAC) labeling of C. elegans to detect changes in the 
phosphorylation levels of a C. elegans ptp-3 knockout strain as compared to wild type. 
This strategy was employed because we rationalized that by removing a phosphatase, the 
phosphorylation levels of its substrates would increase. Therefore, phosphopeptides that 
are more abundant in the mutant can be inferred as either direct or indirect substrates of 
the phosphatase.
However, after initial experiments it was discovered that C. elegans metabolized 
one of the SILAC labels, arginine, into other amino acids, resulting in a dataset that could 
not be accurately analyzed by existing applications. Thus, to salvage the data I built a 
program, PyQuant, that was capable of processing the mass spectrometry data and 
capable of accurately quantifying the SILAC data from C. elegans. Through the use of 
PyQuant, over 60,000 phosphopeptides were quantified, as compared to ~12,000 
quantified by a another program, Proteome Discoverer.
Following this, we realized that PyQuant could be easily adapted to address many 
shortcomings of quantitative mass spectrometry data analysis. This work focuses on the 
development of PyQuant and how it drastically increases the proportion of quantified 
mass spectrometry data and enables advanced data analysis. Lastly, we show how 
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PyQuant was capable of handling the metabolic conversion of SILAC labels in C. 
elegans and was used to identify 225 putative substrates of a tyrosine phosphatase.
Advisor: Akhilesh Pandey, M.D., Ph.D.
Reader: Mark Halushka, M.D., Ph.D.
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1.1 Mass Spectrometry and Proteomics
It is no understatement that mass spectrometry is revolutionizing biological 
studies. Current mass spectrometers are capable of a tremendous throughput, and can 
survey thousands of proteins from complex sample mixtures. This allows for unbiased, 
global surveys of biological systems and is the reason mass spectrometry has been a 
consistent aspect of biomarker and discovery based experiments. Combined with the pace 
of whole genome sequencing, combined applications of proteomics and genomics have 
allowed for a comprehensive description of an organism's genome and proteome 
(Chaerkady et al., 2011; Lasonder et al., 2002). In the context of human disease, this has 
allowed for identification of differentially regulated structural variants (Wu et al., 2013), 
annotation of novel coding regions (Kim et al., 2014a), and re-annotation of existing 
genomic elements such as previously annotated non-coding RNA or pseudogenes 
(Mitchell et al., 2015).
Before delving into the computational workflows involved in proteomics, a 
general understanding of how mass spectrometry data is acquired, and relevant terms 
must be covered. In mass spectrometry, the term MSN (also denoted MSn) is often used 
to describe mass spectrum. The 'N' in MSN refers to the degree a sample is isolated for 
each mass speectra. For instance, a MS1 scan corresponds to the initial, unfragmented 
mass scan that comes directly from the ionization source. In the MS1 scan, the masses of 
1
unfragmented ion species are measured, which in this manuscript corresponds to 
peptides. Ions contained in the MS1 scan can then be isolated and fragmented, which 
produces a MS2 scan. The fragmentation pattern of a MS2 scan can then be used to 
derive information on the composition of the ion species that was isolated in the MS1 
scan. There is no inherent limit to how far a mass spectrometer can isolate and fragment 
an ion species. For instance, the MS2 can be further isolated and fragmented for MS3 
scans, and this process can be repeated iteratively to generate further MSN scans. 
Two various modes are used to select ions for fragmentation and generation of 
MS2 scans: data-independent acquisition (DIA) (Purvine et al., 2003) and data-dependent 
acquisition (DDA). DIA operates by taking a predefined m/z window, fragmenting all 
ions contained within that window, and then repeating this procedure iteratively until it 
covers the full m/z range of the MS1 scan. DDA, on the other hand, operates by 
surveying the full m/z range of a MS1 scan, and then selects a user-defined number of 
ions, usually the most abundant ions, for further fragmentation. As DIA is relatively new, 
DDA is currently the more routinely used method. An important distinction is that DDA 
is a sampling approach, where a set number of ions are selected, usually the most 
abundant, and fragmented. In replicate studies, this strategy can lead to inconsistencies 
within data, as an ion can be chosen for fragmentation is only one replicate. In a complex 
mixture, where many ions of are similar abundance, this can lead to poor concordance 
between replicates and hinder the statistical power of an analysis.
Next, we cover what is actually fragmented. In proteomics, there are several 
methods in which the protein composition of a sample is determined. The most 
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commonly used method is known as bottom-up proteomics. There are several other 
methods including top-down, middle-down, and middle-up – but they will not be covered 
here as they are not frequently used methods. Bottom-up, also referred to as shotgun 
proteomics, is similar in concept to the idea of shotgun sequencing in genomics where a 
protein mixture is broken up into fragments, and these fragments are sequenced with the 
goal of reassembling these fragments into a coherent view of the proteome. The 
fragmentation of the proteome is accomplished through the use of proteolytic enzymes, 
such as trypsin, which hydrolyzes protein sequences into predictable peptide fragments. 
This known fragmentation property is crucial, as it restricts the peptide fragments 
possible to those obeying the cleavage patterns of each enzyme. Search engines can then 
use this information to derive a theoretical set of peptides and spectra to match mass 
spectrum against. Additionally, it restricts the m/z range that ion species will be seen at, 
which allows mass spectrometers to optimize their parameters for a set dynamic range to 
achieve a higher resolution and mass accuracy.
1.2 Processing of mass spectrometry data in Proteomics
Similar to next-generation sequencing technologies, mass spectrometry is 
currently in a deluge of data. As the throughput and capabilities of mass spectrometers is 
rapidly increasing, the computational needs have similarly evolved. Broadly, analysis of 
mass spectrometry data processing as it pertains to proteomics entails three steps: 1) 
acquisition of mass spectra, 2) assignment of MS2 mass spectrum to peptide sequences, 
and 3) inference of proteins from the peptide sequences identified. Optionally, a 
workflow may attempt to quantify the abundance of a peptide species through various 
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methods. The first step of data acquisition is performed by a vendor specific software that 
generates a file annotating the mass spectra. As such, it is outside of the scope of this 
manuscript.
Following spectra acquisition, MS2 spectrum are assigned to peptide sequences. 
The task of assigning MS2 spectrum to peptide sequences is carried out by two 
complementary methods: de novo sequencing and database based spectral assignments. 
De novo methods attempt various combinations of peptide sequences and choose the 
most likely peptide sequence that corresponds to the observed fragmentation spectrum. 
Thus, there is no prior information assumed about the composition of the sample. 
Examples of existing de novo software platforms are PEAKS (Ma et al., 2003) and 
Lutefisk (Taylor and Johnson, 1997). An alternative, and more commonly used, approach 
is the use of protein database driven search engines such as X!Tandem (Craig and Beavis, 
2004), Mascot (Perkins et al., 1999a), or SEQUEST (Eng et al., 1994). In this method, a 
user defines what proteins they wish to identify in a sample and the search engine 
produces theoretical spectra corresponding to the enzymatically cleaved peptides from 
the user supplied input. Then, the search engine proceeds to match experimental spectrum 
against theoretical spectra to determine which theoretical spectra best explain the 
experimental data. This approach is inherently limited by the user supplied input, but for 
well annotated species it is a significantly faster and less computationally intensive than 
de novo methods.
Following assignment of spectra to peptides, the task of inferring the proteins 
each peptide fragment came from begins. Because of similarities within gene families 
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and across genes, there are many peptide sequences that can map to multiple protein 
locations. As such, this results in an ambiguity in how to correctly infer which proteins 
are present in a sample given a list of peptide sequences. Correspondingly, the correct 
way to perform this is a contentious subject. A common method for assigning peptides to 
proteins is the application of Occam's Razor, where the most parsimonious and minimal 
number of proteins given a set of peptides is reported (Serang and Noble, 2012). Though 
there is technically no correct approach, it is important to keep the goals of the 
experiment in mind. For instance, in a purely computational study with no additional 
validation methods, a conservative approach is appropriate. However, if the researchers 
are willing to perform additional validation through methods such as western blotting, a 
liberal assignment of peptides to all possible protein species is acceptable.
The above methods are primarily concerned with the identification of peptide and 
protein species. For many applications, such as identifying the proteins present in a 
sample or discovery of novel genes, a qualitative analysis of mass spectrometry data is 
sufficient. However, when quantitative information is utilized, powerful analyses are now 
possible. For instance, a tumor and a normal tissue can be compared to identify proteins 
that correlate with a pathology (Slebos et al., 2015), or changes in phosphorylation levels 
after a cytokine is applied can reveal new members of well established signaling 
networks (Pinto et al., 2015; Zhong et al., 2012). Thus, quantitative information is a 
decisive benefit of mass spectrometry. In proteomics, there are two common methods for 
peptide quantification, which I will group into MS1 and MS2 based methods. 
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MS1 based quantification relies on information derived from MS1 scans to 
estimate a peptide's abundance. Broadly, the central idea of MS1 based quantification is 
that the abundance of an ion species is proportional to the amount of peptide which was 
eluted and ionized. Thus, by measuring the abundance of an ion species over a time, we 
establish the elution profile of that ion, which is a means to measure the peptide's 
abundance. In practice, a peptide is identified by its MS2 fragmentation spectrum, and 
then the precursor ion in the MS1 scan that produced the MS2 scan is identified. Because 
a peptide can elute over several minutes, the precursor ion is searched for in neighboring 
MS1 scans until it can no longer be detected. Taking the intensity of the precursor ion as 
a function of the time each scan was acquired produces the extracted ion chromatogram 
(XIC). By integrating the XIC, the abundance of the peptide is determined.
MS1 based quantification is useful because it permits quantification of a sample 
without the need for any special reagents. However, to enable studies that focus on 
relative differences between samples, techniques such as stable isotope labeling in cell 
culture (SILAC) have been developed that introduce an isotopically labeled amino acid 
into a sample (Ong et al., 2002). This results in a known mass shift between the unlabeled 
and labeled sample in the MS1 spectra. Thus, the intensity of the unlabeled and labeled 
pair can be used to provide a relative estimate of a peptide's abundance between two 
samples. This technique is particularly powerful because it allows the sample to be mixed 
together following lysis and analyzed on the mass spectrometer simultaneously. 
Therefore, variables that may arise from processing two samples in parallel are mitigated.
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MS2 based quantification, on the other hand, relies on chemically coupling a tag 
to a peptide, often through the use of reactive amine groups on free N-termini or lysine 
residues. Upon fragmentation, this tag is fragmented into an ion of a calculated mass, 
which is referred to as a reporter ion. Through the use of multiple tags of equal mass but 
differing reporter ion masses, it is possible to compare multiple samples simultaneously 
in an MS2 spectrum. A crucial property of this method is that every tag prior to 
fragmentation is of equal mass and therefore appears at the same m/z value in MS1 scans. 
Two common implementations of this method are known as isobaric tag for relative and 
absolute quantification (iTRAQ) (Ross et al., 2004) and tandem mass tags (TMT) 
(Thompson et al., 2003). A primary advantage of these methods is that the sample does 
not have to be grown in the presence of an isotope, which enables its use in human 
samples that would otherwise be problematic to metabolically label. However, a 
downside of these methods is that unlike MS1 scan intensities, MS2 based intensities are 
not comparable to other MS2 scans. Thus, this method enables comparisons between 




PyQuant: A versatile framework for quantitative mass spectrometry data analysis
Introduction
The utility of quantitative MS data is highly dependent on the accuracy and 
comprehensiveness of the tools used for analysis. The first step in quantitative proteomic 
data analysis is to associate spectral information of MS and MS/MS scans with peptide 
sequences, followed by quantification of the identified peptides. This provides two 
avenues to increase the rate of quantification: an increase in spectral assignments and/or 
an increase in the fraction of scans that are quantified. To increase the number of spectral 
assignments, common approaches include the integration of multiple database search 
engines, iterative searches, wide-tolerance searches, and custom database searches (Alves 
et al., 2008; Chick et al., 2015; Kwon et al., 2011; Renuse et al., 2011; Schwartz and 
Gygi, 2005; Shteynberg et al., 2011; Tharakan et al., 2010; Wang et al., 2012).  The major 
benefit of these approaches is an increase in the number of spectra assigned to peptides. 
While increasing the number of spectral assignments allows for a greater number of 
quantitative measurements, it does not address a more fundamental issue that programs 
used for quantitation only quantify a subset of the available data.  Analogous to database 
search engines, each program used for quantitation has its own method for quantifying 
data. Thus, data quantified by one program may be missed by another and there may be 
inherent limitations that are common to several programs.
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An emerging issue as well is that the pace of mass spectrometry data acquisition 
is outstripping many of the existing tools. Currently, the leading platforms for mass 
spectrometry analysis are MaxQuant (Cox and Mann, 2008) and Proteome Discoverer. 
Both platforms are tied to the Windows operating system and GUI based. Because of this 
design, both platforms are unable to make use of computational clusters and require user 
interaction for every experiment run. These features are inherently at odds with 
automated high throughput data analysis pipelines. A third computational workflow, the 
Trans-Proteomic Pipeline (TPP) (Deutsch et al., 2010), is capable of being run via the 
command line and can be used to create highthroughput workflows. However, its ability 
to perform quantitative analysis of mass spectrometry data lags significantly behind the 
capabilities of MaxQuant and Proteome Discoverer and thus, it has not been as well 
adopted.
To address these issues, we have developed PyQuant as a new framework for 
quantitative analysis of MS data. PyQuant is a versatile, cross-platform quantitation tool 
that can be used in conjunction with existing data analysis frameworks  or as a 
quantification node for a minimal, light-weight mass spectrometry data analysis pipeline. 
PyQuant accepts a variety of input formats, including the mzML and pepXML formats, 
several vendor specific formats and allows for generic tab delimited input for formats that 
are not natively supported. Additionally, it is compatible with widely used quantitative 
MS methods such as metabolic labeling (e.g. SILAC, NeuCode, 15N, and 18O) and 
chemical tagging (e.g. iTRAQ and TMT) and allows users to define custom labeling and 
data quantitation strategies. PyQuant can serve as a simple, stand-alone quantitation 
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program following peptide assignment of many search algorithms such as Comet or X!
Tandem (Craig and Beavis, 2004; Eng et al., 2013). This allows the user to have a 
minimal, easily deployed pipeline for mass spectrometry data analysis. Also, PyQuant 
can serve as a post-processor of data analyzed with existing frameworks such as 
MaxQuant, Proteome Discoverer, or the Trans-Proteomic Pipeline (TPP), which allows 
for an additional, independent algorithm to verify existing quantification values as well as 
quantifying data excluded by other algorithms.
Materials and Methods
Preparation of peptide samples for standard MS dataset
A lysine and arginine auxotrophic E. coli strain, SLE1, was purchased from the 
Caenorhabditis Genetics Center (CGC) and grown in M9 Minimal Media (Cold Spring 
Harbor Protocols). Each culture was grown with a mixture of SILAC isotopes at the 
desired mixing ratio, lysed, and fractionated via SDS-PAGE. Gel pieces were excised and 
destained with 40 mM ammonium bicarbonate and 40% acetonitrile (destain buffer) at 
room temperature. Following destaining, samples were reduced by incubation with 5 mM 
dithiothreitol (DTT) for 10 minutes at 60o C. After reduction, samples were alkylated by 
10 mM iodoacetoamide for 20 minutes. Following reduction and alkylation, samples 
were washed with destain buffer and incubated with 100% acetonitrile on ice until 
dehydrated. After dehydration, samples were resuspended in 10 μg/ml trypsin until the 
samples were rehydrated. After this, excess trypsin was removed and the sample was 
digested overnight. Elution of digested peptides was performed by adding 80% 
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acetonitrile with 0.1%  trifluoroacetic acid (TFA) and incubated at 25o C on a shaker for 
20 minutes. After 20 minutes, the supernatant was removed and the eluted peptides were 
lyophilized and stored at -20o C until LC-MS/MS analysis.
For labeling of C. elegans, E. coli strain SLE1 was purchased from the CGC and 
labeled with light and heavy amino acids. Light cultures were grown in LB and heavy 
cultures were grown in M9 Minimal Media (Cold Spring Harbor Protocols) with the 
isotopically labeled amino acids Arginine10 and Lysine8. Each culture was grown 
overnight, and centrifuged at 8,000 x g for 10 minutes at 4oC. For each 250 mL of culture 
pelleted, 50 mL of S. Media (Stiernagle, 2006) was added and the pellet was 
resuspended. For culturing of C. elegans, 50 mL of resuspended E. coli was added to a 1 
L flask with C. elegans and 10 μg/mL of Nystatin to prevent fungal growth. The culture 
was monitored and when the bacteria was almost clear (approximately 3 days) and the C. 
Elegans were isolated in accordance with previously described methods (Stiernagle, 
2006). C. elegans were resuspended in 9M urea containing a protease inhibitor cocktail 
(Roche #10711400), 50 mM beta-galactosidase, 25 mM sodium fluoride, and 1 mM 
sodium orthovandate. Next, the resuspension was tip sonicated and viewed under a 
microscope following sonication until the C. elegans were sufficiently broken apart. 
Following this, the lysate was cleared by centrifugation at 14,000 x g for 20 minutes at 
4oC and protein concentration was measured via BCA. 250 μg from light and heavy C. 
elegans were combined for a total of 500 μg. The lysate was then alkylated with 5 mM of 
iodoacetamide and reduced with 5 mM of dithiothreitol. Following this, the lysate was 
diluted to a final urea concentration of 3M and digested with Lys-c for 4 hours at room 
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temperature. After digestion with Lys-c, the lysate was diluted again to a final urea 
concentration of 1.5M and digested overnight with trypsin. After confirming digestion 
efficiency, the sample was acidified with 1% TFA and centrifuged at 2000 x g for 5 
minutes at room temperature. The supernatant was then loaded onto a Sep-Pak cleanup 
C18 column (Waters, Cat#WAT051910) equilibrated with 0.1% TFA. Columns were 
washed with 12 mL of 0.1% TFA and peptides were eluted with 6 ml of 40% acetonitrile 
with 0.1% TFA. Eluted peptides were then lyophilized and subjected to basic reverse 
phase liquid chromatography and then mass spectrometry analysis.
LC-MS/MS
Peptide samples were analyzed on an LTQ-Orbitrap Elite mass spectrometer 
(Thermo Electron, Bremen, Germany) interfaced with Easy-nLC II nanoflow liquid 
chromatography systems (Thermo Scientific, Odense, Southern Denmark). The peptide 
digests from each fraction were reconstituted in Solvent A (0.1% formic acid) and loaded 
onto a trap column (75 µm × 2 cm) packed in-house with Magic C18 AQ (Michrom 
Bioresources, Inc., Auburn, CA, USA) (5 µm particle size, pore size 100 Å) at a flow rate 
of 5 µl/min with solvent A (0.1% formic acid in water). Peptides were resolved on an 
analytical column (75 µm × 2  0 cm) at a flow rate of 350 nl min−1 using a linear gradient 
of 7–30% solvent B (0.1% formic acid in 95% acetonitrile) over 60 min. Mass 
spectrometry analysis was carried out in a data dependent manner with full scans (350–
1,800m/z) acquired using an Orbitrap mass analyzer at a mass resolution of 120,000 in 
Elite at 400 m/z. The twenty most intense precursor ions from a survey scan were selected 
for MS/MS from each duty cycle and detected at a mass resolution of 15,000 at a m/z of 
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400 in the Orbitrap analyzer. All the tandem mass spectra were produced by higher-
energy collision dissociation (HCD) method. Dynamic exclusion was set for 30 s with a 
10 p.p.m. mass window. The automatic gain control for full FT MS was set to 1 million 
ions and for FT MS/MS was set to 0.05 million ions with a maximum ion injection times 
of 100 ms and 200 ms, respectively. Lock-mass from ambient air (m/z 445.1200025) was 
used for the internal calibration.
Data Analysis
Data analysis on the Proteome Discoverer platform (version 2.0) was performed 
using MASCOT (version 2.2.0) (Perkins et al., 1999a) and SEQUEST (Eng et al., 1994) 
as the search algorithms. For both MaxQuant and Proteome Discovered, the search 
parameters allowed for two missed cleavages; carbamidomethylation at cysteine as a 
fixed modification; N-terminal acetylation, deamidation at asparagine and glutamine, 
oxidation at methionine, and the appropriate SILAC labeling provided as variable 
modifications. For C. elegans data, the variable modifications of phosphorylation at 
serine, threonine and tyrosine were specified. MS data was acquired on the LTQ-Orbitrap 
Elite mass spectrometer, the monoisotopic peptide tolerance was set to 10 ppm and 
MS/MS tolerance to 0.1 Da. The false discovery rate was set to 1% at the peptide level. 
For post-hoc analysis of MaxQuant and Proteome Discoverer, PyQuant was 
provided with the output of each respective program to perform an additional round of 
quantification. PyQuant was provided with the msf output of Proteome Discoverer and 
mzML files of the raw data. For C. elegans, the additional parameter of “--spread” was 
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supplied; otherwise the default parameters were retained (precursor mass error of 5 ppm 
and isotope-selection error of 2.5 ppm). For MaxQuant, the ms_ms.txt table was provided 
as input.
PyQuant's methodology and availability
PyQuant is a command line driven program developed using the Python 
programming language, and is compatible with both Python 2.7+ and Python 3.5+. For 
GUI-based access, PyQuant can be deployed using the Wooey framework 
[https://github.com/wooey/Wooey/]. The web based interface uses jQuery, DataTables, 
pako, and c3 for visualization. Installation instructions, source code, and guides for 
PyQuant are available at https://  pandeylab  .github.io/pyquant/ and it is compatible with 
most major operating systems.
Although PyQuant is capable of quantifying at any msn levels and is highly 
customizable, for simplicity we describe PyQuant's algorithm by stepping through two 
common quantification scenarios: a traditional proteomics label-free data analysis 
pipeline, in which the precursor ion of a ms2 scan is quantified, and an experiment 
utilizing chemical tags such as iTRAQ, where the ms2 scan is used to identify and 
provide quantification of a peptide. However, PyQuant can be configured to quantify at 
any ms level, which allows it to be used with emerging mass spectrometry strategies such 
as ms3-based quantification. Finally, we adopt the term analyte to comprise the physical 
entity of interest, such as a peptide and we use the term ion species to refer to a distinct 
m/z value. The analyte may be comprised of one or more ion species, such as the 
14
monoisotopic peak as well as peaks resulting from the inclusion of naturally occurring 
isotopes.
The steps of PyQuant can be broken down into several distinct steps: input data 
processing, peak picking, and quantification of the extracted ion chromatogram (XIC) 
(Fig. 1). Because of PyQuant's flexibility, there are many ways peaks can be assigned and 
selected. Thus, we cover first how PyQuant processes different types of data, and end 
with a step common to all algorithms, quantification of the XIC.
Input Data Processing
PyQuant accepts a variety of data as input. For data which has been processed 
with other frameworks, PyQuant currently supports the pepXML files created by the TPP, 
msf files produced by Proteome Discoverer, and ms_ms text files produced by 
MaxQuant. For search engines, PyQuant can parse the output of X!Tandem (Craig and 
Beavis, 2004), search engines that produce pepXML files such as COMET (Eng et al., 
2013), and Mascot (Perkins et al., 1999b) if the ms_parser library is installed. To provide 
compatibility with an assortment of programs, PyQuant can also be supplied with a 
generic tab delimited file providing information on spectral assignments. Lastly, PyQuant 
is able to operate solely on raw mass spectrometry data in the mzML format.
Processing of raw data
In the absence of any provided annotation, PyQuant will quantify all ms1 scans 
with a corresponding ms2 scan. This can be used to perform simple analysis of raw data, 
such as identifying intense peaks that may represent sample contaminants, unspecified 
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modifications, or interesting biological findings such as novel or non-tryptic peptides that 
were missing from a database search. PyQuant can also be provided with target ions to 
search for in raw data, which can be used to identify missing values between replicates or 
perform targeted searches for post-translational modifications through the use of 
signature ions.
Processing of mixed resolution data
It is sometimes useful to acquire scans at different resolution levels, such as in 
NeuCode labeling. To assist with this analysis, PyQuant allows a user to define a minimal 
resolution power of a scan to be considered for quantification. This allows the user to 
quantify scans using this time saving data acquisition strategy, which is becoming more 
popular as the resolving power of mass spectrometers increases.
Processing of peptide spectral assignments
After being provided with the output of a given search engine or platform, 
PyQuant begins by parsing result files for peptide spectral assignments (PSMs). 
Following this, PyQuant checks whether a labeling strategy has been defined. For known 
data formats that define the labeling strategies, such Proteome Discoverer's msf file or X!
Tandem's XML output, any user defined labeling strategy is automatically parsed and 
applied. However, for cases where this information is not embedded in the file, or if a 
vendor format changes, the labeling strategy can be supplied as a simple tab delimited 
file. Next, because the mass error changes as a function of the m/z of an ion, the error 
between the theoretical peptide's mass and the observed mass is plotted and fit to a spline 
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function (Supplementary Figure 1). This spline is used to offset the machine drift with 
higher m/z values, which would otherwise make it difficult to identify values at a higher 
m/z within a given error tolerance. PyQuant then identifies the precursor ion of PSMs, 
and if a labeling strategy has been defined, PyQuant searches for corresponding labeled 
peaks in the quantification scans irrespective of whether these peaks have been 
fragmented. This helps to identify and quantify peaks that were not selected for 
fragmentation.
At this point, PyQuant has identified precursor ions and any applicable labeled 
peaks from the PSMs. If the user chooses to quantify scans at the ms1 level, PyQuant 
identifies the isotopic cluster of each precursor ion. However, because each isotopic 
cluster may be comprised of a mixture of overlapping ion species, the profile for each ion 
is fitted to a Gaussian mixture model to remove any interfering ions (Supplementary 
Figure 2). Following this, the peaks for each isotopic cluster are integrated to provide an 
abundance measure for each ion species detected. Finally, this process is repeated for 
neighboring scans until all ion species comprising an analyte can no longer be identified 
in two subsequent scans.
Quantifying the extracted ion chromatogram
To measure the abundance of a given analyte, the extracted ion chromatogram 
(XIC) is generated by extracting intensities from each isotopic peak of an ion species and 
plotting them against their respective retention times. For each XIC, multiple Bi-
Gaussian peaks are fit to the data to accurately model the ion species of interest as well as 
17
any contaminating ions. A Bi-Gaussian peak was chosen because it better models the 
skewness of elution profiles as compared to a Gaussian distribution (Supplementary 
Figure 3). To avoid over-fitting the data with multiple Bi-Gaussian distributions, the 
number of Bi-Gaussian peaks modeling the data is determined using the Bayesian 
information criterion (BIC) (Schwarz, 1978), which guards against over-fitting by 
penalizing additional parameters. Following this, the mean and standard deviations of 
each peak is compared to the retention time the initial scan was identified at, and peaks 
not containing the retention time are excluded. This routine is performed for all isotopic 
clusters and labeled pairs found for a given ion species. Next, because the elution profile 
for isotopic clusters and their isotopically labeled pairs should be similar, the peak shape 
of all isotopic clusters are compared and outlier peaks are identified and excluded by the 
minimum covariance determinant method Supplementary Figure 4A-C) (Rousseeuw 
and Driessen, 1999). Lastly to measure the abundance for each ion, the area under the 
XIC is integrated over.
Confidence Estimates of Quantification
PyQuant uses several approaches to quantify data. However, this can result in the 
inclusion of noisy, unreliable data. To guard against this, PyQuant employs several 
methods to provide an estimate of the accuracy of quantification. PyQuant uses a 
machine learning algorithm trained with a manually curated dataset of “good” and “poor” 
fits to provide a confidence measurement of the quality of fits. This takes into account 
variables such as the signal to noise ratio, the intensity of an analyte, the width of an 
analyte's retention time, and the density of the fitted peak to assess how accurate a given 
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measurement is. Within the dataset of known ratios, selecting only high confidence fits 
results in a tighter distribution of quantified peptides (Supplementary Figure 5). Lastly, 
because there is no substitute for manual validation, PyQuant provides an interactive 
HTML based output that allows a user to filter values, assign cutoffs, and manually 
inspect every isotope selected and the XIC.
Data Output and Visualization
PyQuant provides two files for the user. One is a tab delimited file that can be 
easily viewed in excel or processed further in a given data analysis pipeline. The other is 
a HTML file that offers an interactive browser-based exploration of the data. PyQuant 
uses several open source JavaScript libraries to provide an intuitive user interface with 
advanced data table manipulation. Additionally, PyQuant provides detailed graphics 
depicting which isotopes were selected in each scan, the XIC with corresponding peak 
fits, and integration values for every ion species. This allows the user to make an 
informed choice on whether an ion deemed significant by their chosen criteria, such as a 
fold change between samples, is truly significant or merely an algorithmic error.
Results
The goal of PyQuant is to provide a scalable, versatile framework for MS-based 
quantitative analyses. To demonstrate the various analyses PyQuant enables and its novel 
capabilities, we used publicly available datasets that utilize SILAC (Zhong et al., 2012), 
NeuCode (Merrill et al., 2014), 15N, iTRAQ (Hultin-Rosenberg et al., 2013), and ms3 
based TMT technologies (Murphy et al., 2015).
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PyQuant accurately quantifies a variety of quantitative MS data
To assess PyQuant against a SILAC sample with a known isotopic mixture, three 
separate E. coli cultures were grown with a mixture of light, medium and heavy arginine 
and lysine amino acids in different ratios (Table 1). Following overnight growth, the 
cultures were lysed and processed for LC-MS/MS as described under materials and 
methods. The raw data were analyzed with two existing platforms, MaxQuant and 
Proteome Discoverer in addition to PyQuant. As shown in Fig. 2A, PyQuant was able to 
recapitulate the known sample ratios, and consistently matched SILAC ratios given by 
Proteome Discoverer and MaxQuant. Thus, PyQuant is able to match these existing 
algorithms in quantifying data of known ratios.
While SILAC uses labeling of select amino acids, a similar technique, 15N, labels 
organisms by the metabolic incorporation of 15N isotopes into any nitrogen containing 
amino acids (Washburn et al., 2002). To evaluate PyQuant's ability to handle 15N-based 
quantitative MS data, a 15N labeled mouse liver was compared to an unlabeled mouse 
liver. Equal amounts of proteins extracted from each mouse liver were mixed and 
processed for LC-MS/MS as described under materials and methods. Following peptide 
assignment with Proteome Discoverer, the raw data and search results were processed 
with PyQuant to quantify the relative abundance of 15N to 14N containing peptides. Due to 
MaxQuant and Proteome Discoverer's inability to quantify 15N data, to evaluate the 
performance of PyQuant, spectra were manually interrogated and compared to the ratio 
provided by PyQuant, which confirmed that PyQuant provides values that are consistent 
with manual interpretation (Fig. 2B). 
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A recently developed in vivo labeling technique is NeuCode, where various 
combinations of 13C, 15N, and 2H are incorporated into an amino acid in order to label a 
cell or organism (Hebert et al., 2013). Due to the number of carbons, nitogens, and 
hydrogens in an amino acid, the number of combinations of these isotopes results in 
marked increase in multiplexing capabilities, with up to 36 different mass combinations 
for lysine alone. Currently, no available software supports quantification of NeuCode 
isotopes. Thus, we tested PyQuant's ability to quantify this type of data. An experiment 
with known mixtures of NeuCode labeled lysates was analyzed with PyQuant (Merrill et 
al., 2014). As shown in Fig. 2C, PyQuant was capable of quantifying NeuCode data and 
the median quantification values matched the known isotopic mixtures of each NeuCode 
reagent.
For chemical tagging methods, two common methods are iTRAQ and TMT. Each 
method uses isobaric tags that do not cause a mass shift that can be detected in ms1 scans, 
but upon fragmentation the tags provide relative abundance of each labeled sample. Since 
both methods enables multiplexed comparisons of samples that may not be metabolically 
labeled, such as clinical samples, it has been widely employed in the quantitative 
proteomics field. However, one complication which arises in ms2 based quantification is 
interference from co-fragmentation of background ions, which can systematically skew 
relative abundance measurements (Ow et al., 2009). A solution to this complication is the 
use of ms3 for quantification as opposed to ms2, which reduces the chance of co-
fragmentation of unwanted ions from MS/MS (Ting et al., 2011). We assessed PyQuant's 
ability to quantify at the ms3 level by comparing values derived from PyQuant to 
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previously published ms3 based quantifications (Fig. 2D) (Murphy et al., 2015). This 
revealed that PyQuant was nearly identical to the previously published values and is 
capable of ms3 based quantification.
Increased quantification rate by PyQuant
Because different peaks could be picked by different quantitation programs, 
employing multiple programs should increase the proportion of peptide ions that are 
quantified. In the E. coli data used above, we wished to determine the extent to which 
PyQuant could increase quantification. As shown in Fig. 3A, when analyzing a simple E. 
coli mixture, PyQuant increased the rate of quantification by 68% and 44% when 
compared to Proteome Discoverer and MaxQuant, respectively. To determine how 
confident the quantification of these peptides missed by other programs was, we 
evaluated many of peptides which MaxQuant and Proteome Discoverer failed to quantify 
in PyQuant's output, and determined most of them were accurate (Fig. 3B).
PyQuant can quantify isotopically-labeled peptides with unexpected isotopic patterns
SILAC was initially developed for cell culture systems but is increasingly being 
used for labeling model organisms for global, quantitative analysis of protein abundance. 
A potential complication of SILAC in organisms is the metabolic conversion of 
experimentally introduced labeled amino acids into other amino acids (Borek et al., 2015; 
Van Hoof et al., 2007). Normally, the incorporation of naturally occurring carbon and 
nitrogen isotopes results in the spread of a peptide from its monoisotopic mass, with each 
combination of isotopes appearing as a distinct species in a mass spectrum. Without 
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amino acid conversion, this pattern can be theoretically calculated and used to identify 
which peaks correspond to a peptide of interest. However, when there is an additional 
source of labeled isotopes, such as metabolic conversion of labeled amino acids, the 
isotopic cluster widens and deviates significantly from the theoretical distribution, thus 
complicating the interpretation of protein abundance. 
To evaluate how isotopic conversions impact the quantification of existing 
programs, we labeled the nematode C. elegans with heavy and light amino acids by 
growing them in the presence of labeled bacteria. As shown in Fig. 4A, the use of 
arginine as an isotopic label resulted in the spread of the heavy isotopic cluster, which 
deviated significantly from the isotopic distribution of the unlabeled peak. This data was 
quantified with PyQuant, Proteome Discoverer, and MaxQuant. We found that Proteome 
Discover and MaxQuant routinely underestimated the heavy label's abundance, resulting 
in a systematic bias in the SILAC ratios reported. We hypothesize this may be due to the 
reliance of these algorithms on matching corresponding peaks from each label's isotopic 
distribution thereby ignoring peaks that deviate significantly from the theoretical 
distribution of the isotopic cluster (Fig. 4B). Although restricting the data to known 
theoretical distributions is useful for removing contaminating peaks, in cases such as this, 
it is an incorrect assumption. Thus, to correctly quantify labels that have undergone 
catabolism, parameters in PyQuant can be set to not enforce the theoretical distribution 
on labeled data. With this option, PyQuant correctly identifies and quantifies the entire 
isotopic envelope (Fig. 4C). Thus, PyQuant can be particularly useful in correcting 
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complications arising from metabolic pathways and permits labeling of organisms with 
minimal loss of quantitative information.
Pseudo label-free quantification of isobaric tagging experiments with PyQuant
In ratio based labeling strategies a common pitfall is the absence of a reference 
channel that precludes the ability to calculate a ratio for a given PSM. For large, multi-
plex experiments this is particularly problematic as a missing value in the reference 
channel prohibits the quantification in many samples. To circumvent this, PyQuant can 
provide ms1 and ms2 based measurements of TMT and iTRAQ experiments. This permits 
the traditional, ratio-based strategy to be applied and further allows the user to transform 
each channel into a label-free intensity. We analyzed an experiment that combined known 
concentrations of iTRAQ labeled A549 cell lysates with this hybrid strategy (Hultin-
Rosenberg et al., 2013). We considered how often a chosen reference channel was zero 
and the corresponding ms1 based quantification was available. Using this method, we 
found that depending on which channel was chosen as a reference, the number of 
quantified PSMs increased by 437 to 965, with an average of 700 PSMs (Fig. 5). Thus, 
PyQuant offers the ability to fill in missing values with a psuedo label-free approach, or 
to convert a multiplexed iTRAQ or TMT experiment to a label-free like analysis. 
Targeted ion quantification with PyQuant
In conventional data-dependent acquisition experiments, the most abundant ions 
are chosen for fragmentation. While this approach is useful in most cases, it can lead to 
non-intuitive results in complex samples. For instance, if many ions species exist in a 
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given scan window that are of similar intensities, the mass spectrometer will randomly 
select a set number of ions to fragment. In replicate studies, this has the effect that ions 
selected in one sample may not be chosen for fragmentation in the other sample. This is 
commonly observed in the sometimes poor overlap in PSMs between replicates. To 
overcome this issue, PyQuant can perform targeted searches for peptides identified in one 
replicate that are not fragmented, but present in the ms1 spectra of another replicate.
As a positive control, we evaluated the ability of PyQuant to correctly predict 
missing values between two experimental SILAC experimental replicates. One replicate 
was run through the traditional PyQuant pipeline to establish the true SILAC ratios for 
each peptide and then the search results of the second replicate were used to quantify 
peptides in the first replicate. The traditional run provides the true value of a given 
peptide, and quantifying the first replicate using the search results of the second replicate 
provides an “interpolated” value for a given peptide. However, because we know the true 
value for each peptide, the ability of the missing value search to match the first replicate 
indicates how accurate this method is. This analysis revealed a pearson's correlation of 
0.77 between the true values and the values assigned via the “missing value” search 
(Supplementary Figure 6).
To determine how well this method increased the concordance between replicates, 
we applied PyQuant's missing value analysis to a phosphotyrosine enrichment 
experiment. A recent study evaluated the changes in phosphorylation levels as a function 
of TSLP signaling (Zhong et al., 2012). Upon re-analysis of this data, we found between 
two replicates, one replicate contained 186 phosphotyrosine peptides unique to it and the 
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second replicate contained 131 phosphotyrosine peptides unique to it (Fig. 6A). We 
performed a targeted search for these missing peptides on the raw data of each replicate 
with PyQuant. This targeted search provided replicate information for 77 of these 
phosphopeptides, which increased the concordance quantified phosphopeptides by from 
46% to 59% between the replicates (Fig. 6B). Lastly, we plotted the phosphopeptide fold 
changes for each replicate with and without the missing value analysis. This revealed that 
many peptides followed the same general trend of phosphopeptide abundance between 
the two samples (Fig. 6C).
It is important to note that this approach does have limitations, as many ions can 
appear at identical m/z values and retention times. However, in well controlled 
experiments, we feel this option in conjunction with PyQuant's detailed visual outputs is 
a powerful tool for adding confidence to measured peptides which are considered 
significant in one replicate, but missing in another replicate.
Discussion
As the rate of data acquisition increases in mass spectrometry, GUI based 
applications that require human intervention, such as MaxQuant and Proteome 
Discoverer, are inherently limited in their ability to scale with the pace of MS data. Thus, 
we sought to create a tool that is compatible with existing frameworks as well as able to 
enable the creation of new high throughput mass spectrometry pipelines. To support the 
existing frameworks, PyQuant can be provided with the output from MaxQuant, 
Proteome Discoverer, and the Trans-Proteomic Pipeline. However, to use not explicitly 
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encoded formats, PyQuant can also be provided with a tab delimited file indicating ions 
of interest.
We envision PyQuant as a useful complement to existing tools that can be used to 
provide an additional measure of confidence for quantified values as well as quantify ions 
that were omitted by a given program. Additionally, by providing a single quantification 
node that can plug into a variety of data sources and provides a simple, easily parsed 
output, PyQuant allows the creation of minimal, light weight data analysis pipelines. 
Moreover, by decoupling the quantification of mass spectrometry data from the 
traditional peptide spectrum identification and quantification pipeline, PyQuant opens 
new avenues for novel and highly customized quantification strategies.
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Figure Legends
Figure 1: Overview of PyQuant's data processing algorithm.
Figure 2: PyQuant correctly quantifies various quantitative mass spectrometry data 
methods. A) Two known mixtures of SILAC isotopes in E. coli is quantified with three 
different platforms: PyQuant (red line), MaxQuant (black line), and Proteome Discover 
(blue line). The expected log2 ratios are -2, and 2, which are indicated by a dashed green 
line. All three programs are centered on approximately the same ratios, and have similar 
peak widths. B) PyQuant is able to correctly quantify 15N labeled data. The raw ms1 
spectrum of a peptide from a sample comprised of both 15N and 14N labeled peptides. The 
ratio of the two species as calculated by PyQuant is shown above, which agrees with the 
manual interpretation of the relative abundance levels. C) A multiplexed experiment that 
is labeled with NeuCode is shown. The box-plots indicate the distribution of peptides 
quantified by PyQuant, and the dashed lines indicate known mixture ratios. As shown, the 
median value, represented by a red line within the box-plot, for each ratio measured is 
approximately equal to the known mixing ratio. Thus, PyQuant is capable of reproducing 
the known mixtures of isotopes in the experiment. D) PyQuant is used to quantify a TMT 
10-plex experiment using ms3 fragmentation for quantification. On the x-axis are values 
obtained by Murphy et al. in their study, and on the y-axis are the same values obtained 
by PyQuant. As shown, the values are nearly indistinguishable, providing evidence that 
PyQuant is capable of ms3-based quantification.
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Figure 3: PyQuant is capable of increasing the quantification rates of MaxQuant 
and Proteome Discover. A) The output from MaxQuant was analyzed with PyQuant, 
which resulted in a 44% increase in the number of spectra quantified as compared to 
MaxQuant alone. Similarly, the output from Proteome Discoverer was analyzed with 
PyQuant, which resulted in a 68% increase in the number of spectra quantified as 
compared to Proteome Discover alone. The difference in total spectra between MaxQuant 
and Proteome Discover is due to each program using different search engines for spectral 
assignment. B) The quantification by PyQuant of a peptide which was not quantified by 
MaxQuant is shown. The extracted ion chromatogram for each label is robust with 
multiple isotopomers identified for every label. The quantified ratio as compared to the 
expected ratio for each channel is shown on the right.
Figure 4: PyQuant quantifies isotopic profiles resulting from amino acid 
conversions. A C. elegans sample was labeled with Arginine-10, which was 
metabolically converted to other amino acids.  As seen, this results in a spread of the 
heavy isotopic cluster as compared to the light isotopic cluster. This results in Proteome 
Discover quantifying only a subset of the heavy data, and systematically under-reporting 
Heavy/Light SILAC ratios. PyQuant is capturing and quantifying most of the spread 
isotopic cluster.
Figure 5: Pseudo label-free quantification with PyQuant. PyQuant is used to quantify 
both ms2 and ms1 data of an iTRAQ experiment. PyQuant provides an additional ~400-
1000 quantified PSMs in the dataset, contingent upon which channel was chosen as a 
reference.
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Figure 6: Filling in missing values between replicate studies. A) The Venn diagram 
shows the overlap of hyperphosphorylated peptides from two replicate phosphotyrosine 
enrichments. Over half of the data is not replicated between the two samples. B) After 
performing a missing value search with PyQuant on peptides unique to each replicate, 
peptides which were not fragmented in a given replicate are quantified. This increase is 
shown by the increased overlap between the two replicates. C) The SILAC ratios of 
phosphopeptides between each replicate. Each axis represents the SILAC ratios of a 
particular replicate. Blue circles correspond to phosphopeptides fragmented and 
quantified in both replicates (the overlap in A). Red circles represent the values recovered 
from PyQuant's missing value analysis. Each red circle was fragmented in only one 
replicate, but by using the elution time and precursor ion, the ion is able to be quantified 
irrespective of its fragmentation. As shown, the red and blue circles have a similar trend 
between the two replicates, indicating the missing values follow a similar trend as the 
ions fragmented in both replicates.
Supplementary Figure 1: Re-calibration of mass error as a function of m/z. A) The 
mass error of identified peptides is plotted as a function of the peptide's precursor ion. As 
shown, there is an increase in the mass error as a function of the precursor mass. In green 
is a spline function used to fit this data. B) Using the spline function, the masses from 
panel A are re-calibrated to remove the systematic bias of mass error as a function of m/z.
Supplementary Figure 2: A Gaussian mixture model is used to isolate interfering 
ions. Shown is raw mass spectrometry data in profile mode. The precursor mass of 
interest is at 800.9035, but there is a co-eluting ion which was also detected. To remove 
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this, a Gaussian mixture model is applied to the data, and the true signal of the ion of 
interest can be extracted, which is shown by the red line.
Supplementary Figure 3: Various types of extracted ion chromatograms. Examples 
of the profiles of various extracted ion chromatograms are shown. In orange is the raw 
intensity values of a given ion species as a function of retention time and in blue is the 
curve PyQuant fits to the data. The black line is the retention time of the corresponding 
ms2 scan for each ion. This illustrates the difficulties encountered when fitting a function 
to the elution profile of an ion, and how PyQuant is capable of accurately fitting an 
assortment of data.
Supplementary Figure 4: PyQuant identifies and removes outlier peaks. For each 
panel, the raw and fitted extracted ion chromatograms of a peptide is shown. In orange is 
the raw intensity of each isotopic peak as a function of retention time, with the fitted 
curve shown in blue. Each panel represents the isotopic peaks of an identified peptide. 
Because the elution profile of each isotopic peak should be similar, PyQuant evaluates 
how similar each fitted peak is. The isotopic peak in panel A could be better fit by a more 
skewed peak; however, because this skewness is not present in the isotopic peaks shown 
in panel B and C, the final fit is a less skewed peak.
Supplementary Figure 5: PyQuant's confidence assessment selects for more 
accurate data. Three confidence thresholds for a dataset with a known mixing ratio is 
shown. The data should be centered at 1, and the width of each box-plot shows the 
deviation of the quantified peptides from this value. As peptides below a given 
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confidence threshold indicated on the x-axis are excluded, the deviation of the peptides 
from the true value decreases.
Supplementary Figure 6: Correlated of true values versus interpolated values from 
PyQuant's missing value analysis. On the x-axis are the true Heavy/Light peptide ratios 
from a replicate. The y-axis are these peptides quantified using the retention time and 
precursor ion mass of a replicate. There is a high concordance between the true values 
and interpolated values for each peptide, indicating the missing value analysis is accurate.


























Table 1: Samples grown with known ratios of isotopically labeled amino acids
Mixing Ratios
Lys-0 Lys-4 Lys-8 Arg-0 Arg-6 Arg-10
Sample 1 4 0 1 1 0 4
Sample 2 1 0 1 1 0 1
Sample 3 1 2 4 4 2 1
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CHAPTER 3
Metabolic conversion of isotopically labeled amino acids
Although SILAC has predominantly been utilized in cell cultures, it has been 
increasingly introduced into many model organisms for global, quantitative analysis of 
protein abundance. In the previous chapter, I briefly touched upon a problem PyQuant 
solved: the ability to handle isotopic conversions of labeled amino acids. The conversion 
of isotopically labeled amino acids by the sample has been a known potential 
complication of SILAC (Ong et al., 2003; Van Hoof et al., 2007). In normal cell culture 
experiments it has empirically been found to not be a significant issue; however, in 
organisms it has been observed and the conversion of the isotope has a significant impact 
on the data (Borek et al., 2015; Larance et al., 2011). To further explain this concept, and 
why it matters – what an isotopic cluster is what exactly comprises the cluster will be 
explained in further detail here.
First, we must consider the elemental composition of a peptide sequence. A 
peptide sequence is primarily composed of four elements: carbon, oxygen, nitrogen, and 
hydrogen. An element has a natural distribution of isotopes that are present in varying 
proportions, with the lightest isotope usually being the dominant species. When an amino 
acid is being synthesized, there is no bias in which isotope is incorporated and 
accordingly, there is a random mixture of the isotopes for each element with the 
likelihood of each isotope present being proportional to the natural abundance of that 
isotope. For mass spectrometry, let's imagine there are no isotopes and we are analyzing 
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the peptide sequence PEPTIDE, which contains 34 carbons, 54 hydrogens, 7 nitrogens, 
and 15 oxygens. If on a mass spectrometer, we measure this pure singly charged species, 
we would observed a single peak at a m/z of 800.36724 (Figure 1A).
Now, if we include isotopes, additional peaks corresponding to different 
combinations of isotopes appear. If we have a single heavy isotope in the peptide, a new 
peak at a m/z value corresponding to an additional neutron will be added. An important 
technical detail is that because of mass defects, the additional neutron is not the same 
mass for every element. However, for simplicity, in our treatment we will assume there is 
no mass defect and all neutrons are of equal mass. In our example, an isotope of any 
element can be incorporated into an amino acid at any position. Similarly, there is a 
probability for amino acids being incorporated that contain multiple isotopes. The net 
effect of this is for a peptide to spread from its monoisotopic mass to a distribution that 
reflects the probability of the peptide sequence containing one, two, three, and more 
isotopes (Figure 1B). One important feature is as the peptide sequence becomes longer, 
the monoisotopic peak becomes increasingly smaller, and with long sequences may be 
indistinguishable from noise.
In traditional SILAC experiments, both heavy and light peptide sequences have an 
equal abundance of naturally occurring isotopes in their media. Thus, the isotopic 
distribution of the heavy and light species should be similar (Figure 2A). Without amino 
acid  conversions, this pattern can be theoretically calculated and used to identify which 
peaks correspond to a peptide of interest. Additionally, this information can be used to 
increase the accuracy of selecting the isotopes corresponding to a peptide of interest. If a 
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peak deviates significantly from the expected value, it is likely to be a contaminating ion. 
However, when there is an additional source of labeled isotopes, such as metabolic 
conversion of labeled amino acids, the isotopic cluster widens and deviates significantly 
from the theoretical distribution, thus complicating the interpretation of protein 
abundance (Figure 2B).
To mitigate this conversion, several approaches have been employed. One 
approach is the use of genetic manipulation to prevent the conversion of arginine. In C. 
elegans, the ornithine transferase gene was inhibited by RNAi (Larance et al., 2011) and 
deleted in yeast (Bicho et al., 2010) to disrupt this metabolic pathway. Another approach 
has been to limit the isotopes used for SILAC labeling to lysine, which is not known to be 
metabolically converted. This has been applied in several organisms including C. elegans 
(Fredens et al., 2011), M. musculus (Zanivan et al., 2012), and D. melanogastar (Sury et 
al., 2010). Though these methods are useful for avoiding metabolic conversions, they all 
possess concessions and are situational. Knocking down or deleting genes involved in 
metabolic pathways will have side effects, and creation of a knockdown or knockout in a 
given organism may not be feasible. Utilizing only lysine limits digestion to Lys-C, 
which is significantly more expensive than trypsin, and leaves many peptides longer than 
is optimal for mass spectrometry.
Although experimental methods to avoid metabolic conversions are useful, they 
are stopgap solutions that mask the fundamental issue – that existing computational tools 
are unable to handle metabolic conversions. Many existing tools rely on the theoretical 
isotopic peak pattern to correctly identify the isotopic cluster and provide accurate 
48
SILAC ratios. When these assumptions are invalid, many peptides are incorrectly 
quantified or not quantified at all due to the exclusion of the full isotopic envelope of the 
labeled peptide (Figure 2B). PyQuant was created to surpass this limitation and 
accommodate metabolic conversion of labeled amino acids for accurate SILAC 
quantification. Thus, PyQuant allows for SILAC in organisms without the use of genetic 
manipulation or introducing additional variables such as RNAi. Through the use of 
PyQuant, the amount of peptides quantified in C. elegans was drastically increased. On a 
single dataset, Proteome Discoverer was capable of quantifying ~13,000 peptides while 
PyQuant quantified over 60,000 peptides and when processing the output of MaxQuant, 
MaxQuant quantified ~21,000 peptides while PyQuant quantified over 40,000 peptides 
(Figure 3). The ability to quantify peptides with this unexpected isotopic distribution 
enabled the quantification of our C. elegans data and allows us to pursue our original goal 
– the identification of phosphatase substrates in an organism.
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Figure Legends
Figure 1: An isotopic distribution of a peptide with and without isotopes. A) A 
peptide that is composed of a single isotopic species for all elements contained with the 
peptide. B) A peptide where the natural isotopic abundance of 13C and 15N is taken into 
account. The peptide's abundance is spread over several distinct peaks which correspond 
to the peptide sequence with one or more isotopes present. Notably, the monoisotopic 
peak has diminished in size.
Figure 2: Comparison of a light and heavy SILAC ratio with and without metabolic 
conversion. A) A “normal” SILAC pair is shown that was derived from a sample where 
metabolic conversion of the isotopically labeled heavy amino acids was not occurring. 
The filled blue dots indicate the isotopic peaks that were used to estimate the ion 
abundance of the light and heavy labeled peptides. B) A SILAC pair where the heavy 
label was isotopically converted and incorporated into other amino acids. This results in 
the spread of the isotopic label, as can be seen by comparing the width of the heavy 
cluster as compared to the width of the light cluster. Because of this deviation, the 
program used to quantify the data, Proteome Discoverer, only included the first two 
isotopic peaks from the heavy label.
Figure 3: PyQuant significantly increases the number of quantified peptides in the 
presence of amino acid conversions. A comparison of the numbers of peptides 
quantified of a dataset where conversion of the heavy isotope occurred. The output of 
50
MaxQuant and Proteome Discoverer are processed with PyQuant, which increases the 









Unbiased identification of substrates of protein tyrosine phosphatase ptp-3 in C. 
elegans
Introduction
Tyrosine phosphorylation is a reversible post-translational modification involved 
in most cellular processes. Dysregulation of tyrosine phosphorylation has been implicated 
in a number of human cancers (Hanahan and Weinberg, 2000). The role of tyrosine 
kinases as potent oncogenes has been well described. For example, HER2 is found to be 
amplified in 20% of breast cancers (Slamon et al., 1987), the BCR-ABL translocation is 
observed in nearly all chronic myelogeneous leukemias (Buchdunger et al., 2001) and 
increased expression of EGFR is reported in 40-80% of non-small cell lung cancers and 
50% of primary lung cancers (Kolibaba and Druker, 1997). Protein tyrosine 
phosphatases, on the other hand, have been shown to act as tumor suppressors. Functional 
inactivation of protein tyrosine phosphatases through either mutation or decreased 
expression is associated with a multitude of cancers (Jacob and Motiwala, 2005; Li et al., 
1997; The Cancer Genome Atlas Network, 2012; Veeriah et al., 2009). Recently, protein 
tyrosine phosphatases have also been found to play a role as oncogenes in addition to 
acting as tumor suppressors (Tonks, 2006). For example, deletion of the protein tyrosine 
phosphatase non-receptor type 11 (PTPN11) gene results in increased development of 
hepatocellular carcinoma in mice (Bard-Chapeau et al., 2011) whereas activating 
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mutations or overexpression has been described in several forms of leukemia (Chan et al., 
2008).
Though both protein tyrosine kinases and protein tyrosine phosphatases play 
integral roles in cancer biology, there is a marked discrepancy in our knowledge 
regarding phosphatases as compared to kinases. For instance, although there are 
approximately equal numbers of tyrosine phosphatases and tyrosine kinases in the human 
genome, the phosphorylation database PhosphoSitePlus lists over 1,700 known tyrosine 
kinase substrates while the phosphatase database DEPOD contains ~130 tyrosine 
phosphatase substrates (Duan et al., 2015; Hornbeck et al., 2015). This disparity in our 
knowledge is partly due to intrinsic differences in the experimental methodologies that 
are amenable to studying kinases versus phosphatases. Kinases result in a gain of signal 
that more easily lend themselves to experimental techniques such as radiolabeling ATP to 
identify substrates, or more recently, using mass spectrometry to identify phosphorylated 
sites. Phosphatases, on the other hand, lead to a loss of signal and cannot be studied in a 
straightforward fashion. One approach to identifying phosphatase substrates is the 
creation of substrate trapping mutants in which a catalytically inactive phosphatase is 
used to pull-down interacting proteins and methods such as western blotting and mass 
spectrometry are used to identify substrates. While useful, this approach is an in vitro 
binding method and requires a functional, mutated fusion protein which may not be 
possible to generate easily.
To expand upon the known phosphatase substrates, we sought to apply a high-
throughput  strategy  that  would  lead  to  discovery  of  novel  substrates  of  tyrosine 
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phosphatases in vivo. We reasoned that functionally inactive mutants or knockdowns of a 
phosphatase would result in an increase in the phosphorylation levels of its substrates. 
This,  combined  with  mass  spectrometry,  could  rapidly  identify  hyperphosphorylated 
peptides derived from putative substrates of a protein phosphatase. Moreover, because 
mass  spectrometry  is  used  to  detect  phosphopeptides,  the  actual  sites  that  are 
differentially phosphorylated due to a mutation are revealed.
For this study, we chose to identify substrates of the LAR family of protein 
tyrosine phosphatases. These phosphatases are receptor-like tyrosine phosphatases 
characterized by several extracellular fibronectin and immunoglobulin domains along 
with two intracellular tyrosine phosphatase domains. Within vertebrates, there are at least 
three related genes comprising the LAR family: the LAR receptor protein tyrosine 
phosphatase (PTPRF), protein tyrosine phosphatase receptor type delta (PTPRD), and 
protein tyrosine phosphatase receptor type sigma (PTPRS). PTPRD has been shown to be 
a tumor suppressor gene and has been found to be functionally inactivated in 
glioblastoma multiforme, head and neck cancer, and lung cancer (Veeriah et al., 2009). 
Loss of PTPRS, which is known to dephosphorylate EGFR, has been reported in ~25% of 
head and neck cancers and its deletion in lung cancer results in increased resistance to the 
tyrosine kinase inhibitor erlotinib (Morris et al., 2011).
Given the association between mutations in the LAR family and a number of 
cancers, identification of substrates of the LAR family may help elucidate the molecular 
consequences of these mutations and how they might lead to oncogenesis. However, such 
studies in mouse have been complicated by the functional redundancy between the 
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multiple members of the LAR family. This redundancy can be mitigated through the use 
of multiple gene knockouts; however, existing attempts to knockout multiple members of 
the LAR family have resulted in embryonic lethality (Uetani et al., 2006). To circumvent 
this issue, we used C. elegans as a model system to identify phosphatase substrates in an 
organism which has reduced redundancy but retains many important developmental 
effects of the loss of LAR. The single LAR family homolog in C. elegans, ptp-3, is made 
up of the characteristic extracellular fibronectic and immunoglobulin domains and two 
intracellular tyrosine phosphatase domains that are observed in this family. Similar to its 
human homologs, ptp-3 has been implicated in gastrulation, epidermal development and 
embryonic morphogenesis. Further, deletion of ptp-3 results in smaller brood size due to 
a diminished embryonic viability (Harrington et al., 2002). Here, through the use of 
quantitative phosphoproteomics by employing SILAC labeling of C. elegans, we 
identified 255 putative substrates of ptp-3 and used computational methods to identify 
common motifs for this phosphatase. Further, we identified that kinases were 
overrepresented as substrates of ptp-3, with their kinase activation loop being a common 
target of dephosphorylation by ptp-3.
Materials and Methods
Reagents
The  E.  coli SLE1  strain and  all  C.  elegans  strains  were  purchased  from the 
Caenorhabditis Genetics Center (CGC). Heavy labeled amino acids - arginine (13C6-15N4) 
and lysine (13C6-15N2) were purchased from Cambridge Isotopes Laboratories (Andover, 
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MA). For phosphotyrosine enrichment, anti-phosphotyrosine mouse monoclonal antibody 
(P-Tyr-1000) was purchased from Cell Signaling Technology (Danvers, MA). Nystatin 
(N1638-100ML)  was  purchased  from  Sigma-Aldrich.  Complete,  EDTA-free  protease 
inhibitor  cocktail  tablets  (10711400)  were  purchased  from Roche.  Sequencing  grade 
trypsin and lys-c enzymes were purchased from Promega and TPCK-treated trypsin was 
purchased from Worthington Biochemical Corp. All other reagents were purchased from 
Sigma.
C. elegans metabolic labeling
For SILAC labeling of C. elegans, the bacterial food source was labeled and then 
fed to the C. elegans. For culturing bacteria, light cultures were grown in Lysogeny Broth 
(LB) and heavy cultures were grown in M9 Minimal Media supplemented with 40 µg/ml 
final concentrations of heavy arginine and heavy lysine. Each culture was grown 
overnight, and centrifuged at 8,000 x g for 10 minutes at 4oC. For each 250 ml of culture 
pelleted, 50 ml of S. Medium (Stiernagle, 2006) was added to resuspend the pellet. C. 
elegans were added to a 1 L flask containing 50 ml of resuspended E. coli supplemented 
with 10 µg/ml of Nystatin to prevent fungal growth and grown according to previously 
described methods (Stiernagle, 2006). The culture was monitored and when the bacteria 
was almost clear (approximately 3 days), the C. elegans were pelleted and resuspended in 
0.1 M NaCl. To complete purification, an equal volume of 60% sucrose was added and 
centrifuged for 5 minutes at 900 x g at 4oC. C. elegans at the surface were then pipetted 
off, and washed three times in 50 ml of 0.1 M NaCl to obtain a pure, live population of 
C. elegans.
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C. elegans lysis and protein digestion
C. elegans were resuspended in 9M Urea containing a protease inhibitor cocktail 
(Roche  10711400),  50  mM  beta-galactosidase,  25  mM  NaF,  and  1  mM  Sodium 
Orthovanadate.  Next,  the resuspension was sonicated and viewed under a microscope 
following sonication until the C. elegans were sufficiently broken apart. The lysate was 
cleared  by  centrifugation  at  14,000  x  g for  20  minutes  at  4oC. For  whole  proteome 
experiments, 250  µg from wild type and  ptp-3  lysates were combined, reduced with 5 
mM of dithiothreitol, and alkylated with 5 mM of iodoacetamide. Then, the lysate was 
diluted to a final urea concentration of 3M and digested with lys-c with an enzyme to 
protein ratio of 1:100 for 4 hours at room temperature. After digestion with lys-c, the 
crude digests were diluted to a final urea concentration of 1.5M and digested overnight 
with sequencing grade trypsin with an enzyme to protein ratio of 1:25. After confirming 
digestion efficiency, the sample was acidified with 1% trifluoroacetic acid (TFA) and 
centrifuged at 2000 x g for 5 minutes at room temperature. The supernatant was loaded 
onto a Sep-pak C18 cartridge (Waters, Cat#WAT051910) and equilibrated with 0.1% TFA. 
Desalted  peptides  were  then  lyophilized  and  subjected  to  basic  reverse  phase  liquid 
chromatography. For phosphotyrosine peptide enrichment, 25 mg each from heavy and 
light lysates were combined, reduced with 5 mM of dithiothreitol, and alkylated with 5 
mM of iodoacetamide. Then, lysates were diluted to a final urea concentration of 1.5 M 
and  digested  overnight  with  TPCK-treated  trypsin  (Worthington)  with  an  enzyme  to 




Cat#WAT051910)  and  then  lyophilized  for  subsequent  use  in  phosphotyrosine 
enrichment. 
Immunoaffinity Purification of Tyrosine Phosphopeptides
Immunoaffinity purification (IAP) of tyrosine phosphopeptides was carried out as 
previously described (Kim et al., 2014b; Rush et al., 2005). Briefly, after lyophilization, 
50 mg of peptide mixture was dissolved in 1.4 ml of IAP buffer (50 mM MOPS pH 7.2, 
10 mM sodium phosphate, 50 mM NaCl) and subjected to centrifugation at 2000 × g at 
room temperature for 5 min. Before IAP, P-Tyr-1000 beads (Cell Signaling Technology) 
were washed with IAP buffer twice at 4 °C and the pH of the supernatant containing 
peptides was adjusted to 7.2 by adding 1 M Tris Base. For IAP, the supernatant was 
incubated with P-Tyr-1000 beads (Cell Signaling Technology) at 4°C for 30 min, and the 
beads were washed three times with IAP buffer followed by two washes with pure water. 
Enriched peptides were eluted twice from beads by incubating the beads with 0.15% TFA 
at room temperature.
LC-MS/MS
Peptide samples were analyzed on an LTQ-Orbitrap Elite mass spectrometer 
(Thermo Electron, Bremen, Germany) interfaced with Easy-nLC II nanoflow liquid 
chromatography systems (Thermo Scientific) as previously described (Kim et al., 2014a). 
Peptides were reconstituted in solvent A (0.1% formic acid) and loaded onto a trap 
column (75 µm × 2 cm) packed in-house with Magic C18 AQ (Michrom Bioresources, 
Inc., Auburn, CA, USA) (5 µm particle size, pore size 100 Å) at 280 bar with solvent A 
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(0.1% formic acid in water). Peptides were resolved on an analytical column (75 µm × 15 
cm) at a flow rate of 300 nl/min using a linear gradient of 5–35% solvent B (0.1% formic 
acid in 95% acetonitrile). Mass spectrometry analysis was carried out in a data dependent 
manner with full scans (300–1,700m/z) acquired using an Orbitrap mass analyzer at a 
mass resolution of 120,000 at 400 m/z. The ten and fifteen most intense precursor ions 
from a survey scan were selected for MS/MS from each duty cycle for whole proteome 
and phosphopeptides, respectively, and detected at a mass resolution of 30,000. All the 
tandem mass spectra were produced using higher energy C-trap dissociation method. 
Dynamic exclusion was set for 30 s with a 7 p.p.m. mass window. Internal calibration was 
carried out using lock-mass from ambient air (m/z 445.1200025).
Data Analysis
Tandem mass spectra were processed and searched using MASCOT (Version 
2.2.0) (Perkins et al., 1999) and SEQUEST (Eng et al., 1994) search algorithms against a 
C. elegans WormBase (Harris et al., 2010) database (version 248) through the Proteome 
Discoverer platform (version 2.0, Thermo Scientific). For both algorithms, the search 
parameters included a maximum of two missed cleavages; carbamidomethylation at 
cysteine as a fixed modification; N-terminal acetylation at protein N-termini, deamidation 
at asparagine and glutamine, oxidation at methionine, phosphorylation at serine, 
threonine and tyrosine and SILAC labeling at 13C615N2 lysine and 13C615N4  arginine as 
variable modifications. The mass tolerance for peptide and fragment ions were set to 10 
ppm and 0.1 Da, respectively. The false discovery rate was set to 1% at the peptide level. 
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The probability of phosphorylation for each Ser/Thr/Tyr site on each peptide was 
calculated by the PhosphoRS node in Proteome Discoverer 2.0. 
Following the database search, SILAC ratios were quantified with PyQuant and a 
2-fold  cutoff  was  chosen  to  indicate  a  significant  change  in  a  given  PSM  between 
samples.  For whole proteome measurements, the data was normalized to the median to 
control  for  loading  bias.  After  normalization,  peptide  spectra  matches  (PSMs)  were 
grouped at  the peptide level  and the median value was taken of  each peptide group. 
Following this, the median value of a protein's peptide groups was taken to estimate the 
baseline protein abundance. Next,  in house python scripts were used to provide protein 
level assignments of phosphotyrosine sites (e.g. VLPAATY(phos)LK becomes CE000001 
Tyr582). To normalize loading bias during mixing of samples, the data were normalized 
against  each  enrichment's  corresponding  whole  proteome  experiment.  Identified 
phosphotyrosine sites were then grouped together, and the median value of these groups 
was used to measure the phosphorylation level of each phosphotyrosine site. Finally, the 
abundance level of each site was normalized against the protein abundance measured 
from the whole proteome experiment. If possible, proteins were then mapped to human 
homologs  and  the  corresponding  human  residues  of  phosphotyrosine  sites  were 
annotated.
For mapping C. elegans genes to human homologs, the Wormbase API was used. 
To perform Gene Ontology based clustering and functional annotation, the R package 
clusterProfiler (Yu et al., 2012) and the PANTHER classification system (Mi et al., 2013) 
were used, respectively. For identification of motifs, the surrounding sequence (the 13 
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flanking residues) from each phosphotyrosine site was extracted from the WormBase 
protein database and analyzed using MEME (Bailey and Elkan, 1994) and GLAM2 (Frith 
et al., 2008) to generate motifs. For prediction of sequences containing these motifs, 
motifs generated with MEME were searched using FIMO and predictions with a q-value 
below 10-4 were retained (Grant et al., 2011). For motifs generated using GLAM2, 
GLAM2SCAN was used to predict sequences containing the motif and predictions with a 
score above 15 were kept (Frith et al., 2008).
Data Availability
Mass  spectrometry  derived  proteomics  data  has  been  deposited  to  the 
ProteomeXchange  Consortium  (http://proteomecentral.proteomexchange.org)  via  the 
PRIDE partner repository with the dataset identifier PXD003233.
Results
Deletion of the ptp-3 phosphatase results in increased global tyrosine phosphorylation
A mutant C. elegans strain harboring a mutation in ptp-3, designated RB1878, 
was previously generated by the C. elegans Gene Knockout Consortium. This mutant 
contains a premature stop codon leading to the truncation of ptp-3 prior to its phosphatase 
domains. For quantitative measurements, wild type worms were labeled with heavy 
isotope-labeled lysine and arginine amino acids, and mutant worms were labeled with 
light versions of these amino acids. Following a label check to confirm incorporation of 
the heavy isotope, samples were lysed and protein concentration was measured. From 
each sample, 25 mg of lysate was taken, mixed, and digested in-solution with trypsin and 
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subjected to an antibody based phosphotyrosine enrichment and LC/MS-MS analysis 
(Figure 1) as described previously by our group (Syed et al., 2015; Zahari et al., 2015; 
Zhong et al., 2012). Peptides were identified using Mascot and Sequest run through 
Proteome Discoverer 2.0 and quantified using PyQuant.
Two biological replicates of wild type and ptp-3 mutants each were grown, lysed, 
and subjected to phosphotyrosine enrichment and whole proteome analysis. First, we 
assessed proteomic changes of the ptp-3 knockout on C. elegans. From our analysis, we 
identified 2,130 proteins encoded by 1,266 genes, with 148 proteins encoded by 72 genes 
that were upregulated and 29 proteins encoded by 20 genes that were downregulated in 
the ptp-3 knockout (Supplementary Figure 1A). To assess the possible impact of the 
knockout, we performed a Gene Ontology (GO) analysis (Ashburner et al., 2000) using 
the PANTHER classification system (Mi et al., 2013). GO analysis of genes revealed an 
enrichment for genes involved with developmental processes (Supplementary Figure 
1B), which is consistent with the known phenotype of increased embryonic lethality and 
abnormal morphology in the ptp-3 knockout.
Using antibody-based phosphotyrosine peptide enrichment, we identified 3,021 
phosphotyrosine  containing  peptides.  We  grouped  the  identified  peptides  by  their 
phosphotyrosine site (e.g. y543). This analysis identified 1,463 different phosphotyrosine 
sites. Because global protein changes in ptp-3 knockout worms may be falsely inferred as 
changes  in  phosphorylation  levels,  protein  levels  determined  from  whole  proteome 
analysis  were  used  to  correct  for  protein  fluctuations  that  may  contribute  to 
phosphotyrosine  measurements.  We considered  a  site  hyper  or  hypophosphorylated  if 
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there was at least a 2-fold change in the phosphorylation state between the wild type and 
mutant  samples.  Using  these  criteria,  we  identified  255  sites  that  were 
hyperphosphorylated and 264 that were hypophosphorylated in the ptp-3 mutant (Figure 
2). As a phosphatase, knockout of ptp-3 predicts an increase in phosphorylation levels of 
its substrate(s); therefore, we consider these 255 hyperphosphorylated sites to be potential 
substrates of ptp-3.
To evaluate the general impacts of the loss of ptp-3 mediated dephophorylation, 
we analyzed hyperphosphorylated tyrosine sites in the ptp-3 knockout. A GO analysis of 
putative substrates was performed using clusterProfiler (Yu et al., 2012). Similar to the 
whole proteome, GO analysis revealed enrichment of genes related to reproduction, 
anatomical development and embryo development.
Conservation of putative substrates in humans
Due to evolutionary changes from C. elegans to H. sapiens, putative substrates 
identified in C. elegans may not be conserved across species. Moreover, conservation is a 
strong predictor of functionality, and sites that are conserved across species are more 
likely to be true positives than those that are found only in C. elegans (Tan et al., 2009). 
Thus, for our subsequent analysis we focused only on putative substrates that were 
conserved in C. elegans and humans.
We performed a search using Wormbase (Harris et al., 2010) to locate 
homologous genes of the identified putative ptp-3 substrates. This analysis revealed 145 
putative substrates with clearly defined human homologs. Next, Clustal Omega (Sievers 
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et al., 2011) was used to align each C. elegans protein sequence to its human homolog 
and to determine if the specific phosphotyrosine site was conserved in humans. Of the 
145 putative substrates with homologs in humans, 46 contained a tyrosine residue in both 
species at the identified hyperphosphorylated tyrosine site. Interestingly, we also found 
that in 11 cases the tyrosine residue that was hyperphosphorylated in C. elegans was 
replaced by a phenylalanine in the orthologous sequence in humans. This is of note 
because mutational studies often mutate tyrosine residues to phenylalanine in order to 
prevent phosphorylation yet retain the structural importance of aromatic side chains. 
Thus, these residues may not be crucial for signaling in humans, but could have important 
roles in structure-based interactions.
Site level resolution of known substrates of the LAR family
To evaluate the success of our profiling approach, we compared the list of 
proteins that were hyperphosphorylated in the ptp-3 mutant with C. elegans orthologs of 
previously described substrates of the LAR family. We chose to use the substrates of the 
LAR family members in the human dephosphorylation database DEPOD (Duan et al., 
2015) because currently there are no databases listing dephosphorylation events in C. 
elegans, there is no entry for ptp-3 in the Worm Interactome Database (Simonis et al., 
2009), and we are unable to find known substrates of ptp-3 in the literature through 
PubMed searches.
At this time, the DEPOD database contains nine known substrates of the LAR 
family, with three substrates belonging to the same gene family. Of the known substrates, 
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only Tyr705 of  STAT3 was annotated as the site that is dephosphorylated by  PTPRD. 
Remarkably, in our data, we identified orthologs of four of the nine known substrates, 
NTRK2, MET, INSR, and STAT3 (sites indicated in figure 2), to be hyperphosphorylated 
with a conserved tyrosine residue. Additionally, the C. elegans ortholog of STAT3, sta-1, 
was found and the C. elegans site corresponding to Tyr705, Tyr588, exhibited a 5.6 fold 
increase in phosphorylation levels in the ptp-3 knockout. This shows we are able to find 
known gene products which are dephosphorylated by the LAR family in addition to the 
site which has previously been shown to be dephosphorylated.
The DEPOD database listed only one substrate where the actual tyrosine residue 
that  is  dephosphorylated  was  confirmed.  This  is  an  important  limitation  to  known 
enzyme-substrate relationships; that even when experimental evidence shows a protein is 
dephosphorylated by a  phosphatase,  the exact  sites which are modified are  often not 
known.  Since  mass  spectrometry  was  used  to  identify  substrates  in  this  study,  it 
inherently  provides  site  level  resolution  as  well  as  quantitative  measures  of 
phosphorylation.  As discussed above,  in  our data three substrates,  NTRK2, MET, and 
INSR, were known to be dephosposphorylated in humans although their actual site or 
sites of dephosphorylation was unknown. We identified conserved hyperphosphorylated 
sites mapping to these three genes as well as a hyperphosphorylated site that has been 
previous described. This illustrates that our approach is able to provide highly confident 
sites  for  future functional  studies that  further  dissect  phosphorylation based signaling 
networks.
Putative substrates of ptp-3 are enriched in kinases
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Next, we performed a GO analysis for biological processes of the conserved 
putative substrates of ptp-3, which revealed a significant enrichment for kinases (q-value 
5.9 * 10-27). Of these genes included in the GO analysis, we found that 15 conserved 
hyperphosphorylated sites were located in kinases. We then examined the location of the 
phosphosite in each kinase, and found that 6 sites were in the activation loop and have 
previously been shown to be critical for kinase activation (Figure 3). Additionally, 
several sites were identified that were not in the activation loop, but conferred important 
catalytic activity. For example, Tyr579 of PDGFRB and Tyr15 CDK5 were 
hyperphosphorylated, and phosphorylation of these sites has been shown to increase 
kinase activity (Baxter et al., 1998; Zukerberg et al., 2000). Tyr1356 of MET was 
hyperphosphorylated, which is not known to increase kinase activity, but has been shown 
to be crucial for transduction of signals involving cell motility, morphogenesis, and 
tubule formation (Dekel et al., 2003).
Next, we sought to determine whether a common motif exists within the putative 
substrates of ptp-3. We selected the identified conserved hyperphosphorylated tyrosine 
sites and 13 amino acids surrounding each site as the input sequences for motif 
prediction. These sequences were scanned for common motifs using GLAM2 (Frith et al., 
2008) and MEME (Bailey and Elkan, 1994), two motif identification programs that are 
part of the MEME suite (Bailey et al., 2009). This analysis revealed two motifs where the 
hyperphosphorylated tyrosine residue was located at the 0 position (Figure 4A; 4B). 
Next, we used these motifs to predict additional substrates of ptp-3 and the LAR family 
by searching against the human RefSeq protein database with GLAM2SCAN (Frith et al., 
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2008) and FIMO (Grant et al., 2011), two programs that take the respective output of 
GLAM2 and MEME and identify sequences containing a given motif. The motif 
identified by GLAM2 (Figure 4A), was present in 65 proteins encoded by 20 genes while 
the MEME motif (Figure 4B) was identified in 108 proteins encoded by 29 genes. 
Significantly, 12 of the 20 genes containing the GLAM2 motif (60%) and all 29 genes 
containing the MEME motif are kinases, implying an important role for ptp-3 and the 
LAR family in the regulation of kinases.
Given the abundance of kinases identified through our profiling approach, and 
that many hyperphosphorylated tyrosine residues were responsible for increased kinase 
activity, this suggests that functional inactivation of a LAR family member likely leads to 
increased kinase activity. Taking into account the known oncogenic potential of kinases, 
this data presents a possible link between the mutation of various LAR family members 
and associated cancers (FUNATO et al., 2011; Giefing et al., 2011; Morris et al., 2011; 
Veeriah et al., 2009). Although our profiling approach was able to recapitulate many 
known substrates of the human homolog of ptp-3 and provided broad implications to the 
regulatory roles of ptp-3 and the LAR family in humans, it should be noted these are 
putative substrates and do not supplant directed mutational studies and in vitro assays for 
final confirmation. However, given the ability of this approach to capture much of what is 
known, we feel the hyperphosphorylated peptides identified in this study are excellent 
candidates for further validation including functional studies to precisely map out the 
LAR family's dephosphorylation network.
Discussion
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The C. elegans LAR-like receptor tyrosine phosphatase, ptp-3, is expressed in 
several tissues during C. elegans development and has been shown to play a role in 
gastrulation and neural morphogenesis (Chin-Sang et al., 2002; Harrington et al., 2002). 
A human homolog of ptp-3, PTPRD, has been found to be deleted or functionally 
inactivated in several cancers, with inactivation of PTPRD occurring in over 50% of 
GBM tumors (Veeriah et al., 2009). A recent study identified Tyr705 of STAT3 as a 
specific target of PTPRD. In our data, we found the C. elegans STAT orthologs in 
humans to be hyperphosphorylated at Tyr588, which upon alignment to the human STAT3 
protein, corresponds to Tyr705 of STAT3. Interestingly, another receptor tyrosine 
phosphatase, PTPRK, has been shown to dephosphorylate Tyr705 of STAT3 as well (Chen 
et al., 2015). Given that multiple homologs of ptp-3 exist in humans, this may indicate 
that putative substrates found in our study may be common to multiple protein receptor 
type tyrosine phosphatases.
Many substrates of the LAR-like receptor tyrosine phosphatases are known only 
at the protein level and lack site level resolution. PTPRF has been shown to 
dephosphorylate the insulin receptor (INSR), beta-catenin, and hepatocyte growth factor 
receptor (MET) but there is no site level resolution (Hashimoto et al., 1992; Machide et 
al., 2006; Müller et al., 1999). In our data, we find hyperphosphorylated tyrosine residues 
corresponding to the C. elegans homologs of INSR and MET. In the C. elegans homolog 
of INSR, daf-2, we find two hyperphosphorylated sites, Tyr1419 and Tyr1420, which are 
both conserved in humans. For MET, we find several hyperphosphorylated sites in its C. 
elegans homolog svh-2 as well. While only one of these sites is conserved in humans, we 
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note that there are nearby tyrosine residues which may be the functionally equivalent site 
in humans. PTPRS has been shown to dephosphorylate the epidermal growth factor 
receptor (EGFR) and members of the neutrotrophic tyrosine kinase receptors NTRK1, 
NTRK2, and NTRK3 (Faux et al., 2007; Vijayvargia et al., 2004). We find 
hyperphosphorylated tyrosine residues in both of the C. elegans homologs of these genes. 
For EGFR, like MET, the hyperphosphorylated residue is not conserved in the human 
homolog, but once again a conserved tyrosine residue is near the site identified in C. 
elegans. For the neutrotrophic tyrosine kinase receptors, we identified a 
hyperphosphorylated Tyr632 in the C. elegans homolog trk-1, which is conserved in the 
human sequence as well.
When considering the known literature,  our study was able to identify known 
proteins dephosphorylated by the LAR-like receptor tyrosine phosphatases, and provided 
potential  sites  of  substrates  known  to  be  dephosphorylated  by  PTPRF and  PTPRS. 
Additionally,  we  provide  an  extensive  catalog  of  potential  substrates  of  ptp-3  in  C. 
elegans,  many of which are related to the known developmental roles of  ptp-3  in  C. 
elegans.  In humans, many of the potential substrates were found to be kinase-related, 
with  9  of  the  hyperphosphorylated  tyrosine  residues  having known effects  on kinase 
activity, which may explain why functional inactivation of PTPRD, PTPRF, and PTPRS 
have been found in multiple cancers. Given the numerous knockouts in C. elegans, our 
strategy can be applied to identify potential substrates of additional phosphatases as well 




Figure 1: Overall strategy of phosphotyrosine peptide enrichment and LC-MS/MS 
analysis.  The  experimental  workflow  for  labeling  of  C.  elegans,  phosphotyrosine 
enrichment and LC-MS/MS is shown. First,  E. coli  cultures were grown with SILAC 
isotopes and then fed to C. elegans over several generations until the worms were fully 
labeled. Following label incorporation, wild type and mutant samples were lysed and an 
equal protein amount of each labeled lysate was mixed together. Following mixing, one 
portion of the sample was subjected to whole proteome LC-MS/MS analysis  and the 
remaining portion was subjected to phosphotyrosine peptide enrichment and LC-MS/MS 
analysis.
Figure  2:  Distribution  of  phosphotyrosine  sites  identified.  The  relative  change  in 
phosphorylation levels of phosphotyrosine sites between the ptp-3 mutant and wild type 
is shown. Higher values on the y-axis correspond to increases in phosphotyrosine levels 
with a tyrosine phosphatase mutation. The red dashed line indicates a 2 fold increase in 
tyrosine phosphorylation, and the blue dashed line indicates a 2 fold decrease in tyrosine 
phosphorylation. Shapes with their corresponding gene are known substrates of human 
homologs of ptp-3, and show that this study identifies known phosphotyrosine substrates 
as being hyperphosphorylated. 
Figure  3:  Activating  residues  of  kinases  that  are  hyperphosphorylated.  Tyrosine 
residues  with  increased  phosphorylation  in  the  ptp-3  knockout  are  depicted,  with the 
identified residue indicated in red. The first six rows correspond to tyrosine residues that 
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are located in the activation loop of the indicated gene, and the last three rows correspond 
to tyrosine residues that have been shown to alter kinase activity.
Figure 4: Motif analysis of hyperphosphorylated tyrosine sites. A) A motif identified 
by MEME for hyperphosphorylated tyrosine residues. The zero position for the motif 
indicates the hyperphosphorylated tyrosine residue. B) A motif identified by GLAM2 for 
hyperphosphorylated  tyrosine  residues.  The  zero  position  for  the  motif  indicates  the 
hyperphosphorylated tyrosine residue.
Supplementary  Figure 1:  Whole  proteome analysis  of  the  ptp-3  mutant.  A)  The 
distribution of protein abundance between the ptp-3 mutant and wild type strain measured 
at the global proteome level is shown.  B) A GO analysis of genes up-regulated in the 
whole  proteome  data  shows  an  enrichment  for  genes  involved  in  developmental 















In my thesis, I set out to characterize the substrates of a tyrosine phosphatase 
through SILAC based phosphoproteomics. Because we used an organism instead of cell 
culture, metabolic pathways interfered with our labeling strategy and resulted in data that 
was not compatible with existing programs. To rectify this, PyQuant was created and 
used to quantify the C. elegans data. This analysis revealed a plethora of putative 
substrates of the C. elegans protein tyrosine phosphatase ptp-3 and uncovered the few 
known substrates of the human orthologs of ptp-3. In total, there are approximately 9 
known substrates of the LAR family. Following this study, we reported 255 putative 
substrates of the LAR family, which is over an order of magnitude increase in the 
possible substrates of the LAR family. Though these are all putative substrates and need 
additional validation measures, the conservation of many putative substrates from C. 
elegans to humans and the number of known substrates rediscovered in the C. elegans 
data suggest a fair portion of the putative substrates may validate. In addition to the work 
described herein, we attempted two validation measures: shRNA knockdown of ptp-3 and 
a GST fusion protein. These validation efforts were unfortunately unsuccessful. The 
shRNA did not completely knock down the phosphatase as it was still found in the mass 
spectrometry data and the GST fusion protein was functionally inactive. Thus, the proper 
folding conditions need to be established to validate these substrates in C. elegans or a 
GST fusion protein from another species may need to be used in its stead.
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Following the use of PyQuant to handle the C. elegans data, it was further 
developed to solve an assortment of problems in quantitative mass spectrometry. A 
notable case is the “missing value problem” in proteomics. A recurrent issue in replicate 
analysis, especially in phosphotyrosine enrichment assays, is poor concordance between 
samples. Due to DDA, the notion of a replicate in mass spectrometry is different than in 
most experimental assays. For instance, a western blot does not randomly sample the 
proteins being transferred in an all-or-none fashion. However, most experimentalists have 
the same expectations of a mass spectrometry replicate as a western blot replicate. This 
“missing value analysis” feature will significantly help in complex samples such as 
phosphotyrosine enrichment, where significant improvements in replicate concordance 
have already been observed.
Finally, a central ideology of PyQuant is that a user should be able to interrogate 
their data and see exactly how it was quantified. In existing platforms, the chain of 
custody of how data is manipulated and quantified is obscured. Proteome Discoverer 
currently gives the most information by reporting the abundance of each isotopic cluster. 
However – the XIC, the isotopes chosen in each scan, and how the data was fit – the 
factors that comprise the final data are hidden. Whatever their reasons are for not 
presenting this data, it can mask flaws in the data analysis. Given that in a normal 
proteomics experiment, there may only be tens or hundreds of peptides of interest, 
manual validation on every peptide is not a cumbersome routine as it is exceedingly easy 
to visually determine if data is trustworthy. Thus, while existing applications ask the user 
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to trust their quantification of ions, PyQuant lets the user manually validate ions that may 
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